Laurel Wealth Advisors (California)’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$9.76M Buy
55,231
+2,739
+5% +$473K 0.96% 15
2022
Q3
$8.57M Sell
52,492
-126
-0.2% -$21.3K 0.91% 19
2022
Q2
$9.34M Sell
52,618
-3,416
-6% -$609K 0.95% 16
2022
Q1
$9.93M Sell
56,034
-1,215
-2% -$207K 0.82% 18
2021
Q4
$9.79M Buy
57,249
+9,830
+21% +$1.61M 0.76% 21
2021
Q3
$7.66M Sell
47,419
-2,220
-4% -$379K 1.41% 9
2021
Q2
$8.18M Buy
49,639
+1,374
+3% +$227K 1.06% 13
2021
Q1
$7.93M Buy
48,265
+3,845
+9% +$622K 1.2% 12
2020
Q4
$6.99M Buy
44,420
+2,641
+6% +$390K 1.03% 16
2020
Q3
$6.22M Sell
41,779
-60
-0.1% -$8.88K 1.03% 18
2020
Q2
$5.88M Buy
41,839
+4,842
+13% +$706K 1.08% 15
2020
Q1
$4.85M Buy
36,997
+1,545
+4% +$219K 1.11% 12
2019
Q4
$5.17M Sell
35,452
-11,431
-24% -$1.55M 0.87% 22
2019
Q3
$6.07M Buy
46,883
+1,096
+2% +$144K 1.04% 13
2019
Q2
$6.38M Sell
45,787
-2,736
-6% -$379K 1.4% 6
2019
Q1
$6.78M Buy
48,523
+675
+1% +$90.4K 1.67% 4
2018
Q4
$6.17M Sell
47,848
-2,168
-4% -$302K 1.82% 5
2018
Q3
$6.91M Sell
50,016
-795
-2% -$106K 1.7% 4
2018
Q2
$6.17M Buy
50,811
+175
+0.3% +$21.8K 1.64% 4
2018
Q1
$6.49M Sell
50,636
-1,729
-3% -$234K 2.01% 3
2017
Q4
$7.32M Buy
52,365
+1,977
+4% +$275K 2.11% 2
2017
Q3
$6.55M Buy
50,388
+92
+0.2% +$12.2K 2.2% 2
2017
Q2
$6.65M Buy
50,296
+3,317
+7% +$423K 2.36% 2
2017
Q1
$5.85M Buy
46,979
+500
+1% +$59.7K 2.26% 4
2016
Q4
$5.35M Buy
46,479
+116
+0.3% +$13.4K 2.37% 3
2016
Q3
$5.48M Sell
46,363
-730
-2% -$88.6K 2.59% 2
2016
Q2
$5.71M Sell
47,093
-51
-0.1% -$5.79K 2.74% 2
2016
Q1
$5.1M Sell
47,144
-1,049
-2% -$109K 2.56% 3
2015
Q4
$4.95M Buy
+48,193
New +$4.85M 2.56% 3

Other funds holding JNJ

Laurel Wealth Advisors (California)'s JNJ Position: Q4 2022 in Review

Laurel Wealth Advisors (California) increased its Johnson & Johnson (JNJ) stake by 5.2% in Q4 2022, buying an estimated $473K and bringing the position to 55,231 shares worth $9.76M. The position accounts for 0.96% of the portfolio, ranked #15.

Laurel Wealth Advisors (California) first reported a position in JNJ in Q4 2015 and has held it in 29 quarters since. The position peaked at $9.93M in Q1 2022. 3,788 funds tracked by Wall St. Rank hold JNJ as of Q4 2022.

  • Laurel Wealth Advisors (California) held 55,231 shares of Johnson & Johnson worth $9.76M as of Q4 2022.
  • Laurel Wealth Advisors (California) bought 2,739 Johnson & Johnson shares in Q4 2022, an estimated $473K.
  • Johnson & Johnson made up 0.96% of Laurel Wealth Advisors (California)'s portfolio in Q4 2022, its #15 holding.
  • Laurel Wealth Advisors (California) first reported a position in Johnson & Johnson in Q4 2015 and has held it in 29 quarters since.
  • Laurel Wealth Advisors (California)'s Johnson & Johnson position peaked at $9.93M in Q1 2022.
  • 3,788 funds tracked by Wall St. Rank held Johnson & Johnson as of Q4 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q4 2022, filed 14 Feb 2023.